Zhejiang Tailin BioEngineering Co.,Ltd (300813.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.98B
Enterprise Value2.83B
P/E Ratio105.73
PEG Ratio8.99
Price/Sales Ratio6.92
Price/Book Ratio3.05
Enterprise/Revenue6.49
Enterprise/EBITDA63.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue334.41M
Revenue/Share2.99
Gross Profit140.13M
EBITDA37.34M
Net Income16.49M
Diluted EPS0.14

Balance Sheet

Total Cash292.49M
Total Cash/Share2.46
Total Debt0
Total Debt/Equity0
Current Ratio3.61
Book Value Per Share6.66

Price History

52-Week Change-40.9
52-Week High42.25
52-Week Low16.38
Moving Average 50 Days20.09
Moving Average 200 Days23.72

Statistics

Average Volume2.77M
Shares Outstanding121.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.13
Trailing Annual Dividend Yield0.64
Payout Ratio1.19
Last Split Factor13:10
Last Split DateMay 11, 2023
AD